The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression
- PMID: 12851675
The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression
Abstract
We have previously described the expression of interleukin cytokines (IL)-1alpha, IL-1beta, and IL-1 receptor antagonist (IL-1ra) in human breast cancer (HBC) tissue. Based on our previous studies, we hypothesize that the IL-1 family of cytokines, antagonists (IL-1ra) and receptors (IL-1RI and IL-1RII) are present within the human breast cancer (HBC) tumor microenvironment and that the IL-1 network of cytokines and receptors within the tumor microenvironment can control tumor cell subpopulation expression of other protumorigenic cytokines such as the angiogenic/growth factor, interleukin-8 (IL-8). To test this hypothesis we characterized the in vivo expression of the IL-1 network in HBC tissues and homogenates by immunohistochemistry (IHC) and ELISA. Additionally, we examined IL-1R expression in HBC cell lines in vitro and in a murine xenograft model by IHC. Finally, we determined the ability of IL-1 to induce IL-8 expression in in vitro using HBC cell lines. We observed that not only are the IL-1 cytokines present in HBC tissue and homogenates, but that IL-1Rs and IL-8 are also present in the HBC tumor microenvironment. Additionally, expression levels for some members of the IL-1/IL-8 network of cytokines correlated with the prognostic indicators, ER/PR. Using HBC cell lines, we observed that HBC cell lines express IL-1Rs in vitro and in the xenograft model. Furthermore, in vitro, HBC cell lines show a spectrum of responsiveness to IL-1 as measured by expression the proangiogenic/mitogenic cytokine IL-8. Our data clearly demonstrate the presence and distribution of IL-1 cytokines and receptors in HBC and suggests that the local expression of IL-1 results in the activation of a population of cells within the HBC tumor microenvironment. This activation of the IL-1/IL-1R cytokine family via autocrine and/or paracrine mechanisms leads to a cascade of secondary protumorigenic cytokines. These secondary signals induce the expression of numerous protumorigenic activities such as the expression of IL-8, and subsequently contribute to angiogenesis, tumor proliferation, and tumor invasion.
Similar articles
-
In vitro demonstration of breast cancer tumor cell sub-populations based on interleukin-1/tumor necrosis factor induction of interleukin-8 expression.Oncol Rep. 2003 Jul-Aug;10(4):1011-7. Oncol Rep. 2003. PMID: 12792762
-
Interleukin 1 system and sex steroid receptor expression in human breast cancer: interleukin 1alpha protein secretion is correlated with malignant phenotype.Clin Cancer Res. 2003 Oct 15;9(13):4877-83. Clin Cancer Res. 2003. PMID: 14581361
-
Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma.Cancer. 2004 Apr 1;100(7):1388-96. doi: 10.1002/cncr.20142. Cancer. 2004. PMID: 15042672
-
Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist.Int Rev Immunol. 1998;16(5-6):457-99. doi: 10.3109/08830189809043005. Int Rev Immunol. 1998. PMID: 9646173 Review.
-
Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.J Clin Invest. 1991 Nov;88(5):1445-51. doi: 10.1172/JCI115453. J Clin Invest. 1991. PMID: 1834696 Free PMC article. Review.
Cited by
-
Recombinant Human IL-32θ Induces Polarization Into M1-like Macrophage in Human Monocytic Cells.Immune Netw. 2024 Jun 24;24(3):e27. doi: 10.4110/in.2024.24.e27. eCollection 2024 Jun. Immune Netw. 2024. PMID: 38974209 Free PMC article.
-
Oestrogen receptor negative breast cancers exhibit high cytokine content.Breast Cancer Res. 2007;9(1):R15. doi: 10.1186/bcr1648. Breast Cancer Res. 2007. PMID: 17261184 Free PMC article.
-
Non-Inflammasome Forming NLRs in Inflammation and Tumorigenesis.Front Immunol. 2014 Apr 22;5:169. doi: 10.3389/fimmu.2014.00169. eCollection 2014. Front Immunol. 2014. PMID: 24795716 Free PMC article. Review.
-
Inflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor Development.Front Immunol. 2017 Sep 12;8:1132. doi: 10.3389/fimmu.2017.01132. eCollection 2017. Front Immunol. 2017. PMID: 28955343 Free PMC article. Review.
-
c-Myb interferes with inflammatory IL1α-NF-κB pathway in breast cancer cells.Neoplasia. 2021 Mar;23(3):326-336. doi: 10.1016/j.neo.2021.01.002. Epub 2021 Feb 20. Neoplasia. 2021. PMID: 33621853 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials